Search Results

You are looking at 101 - 110 of 793 items for :

  • "screening" x
Clear All
Full access

Kristopher J. Kimball and Warner K. Huh

significance: a two-year prospective study . Am J Obstet Gynecol 2003 ; 188 : 1401 – 1405 . 5. Partridge EE Abu-Rustum N Campos S . The NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer Screening, version 1 , 2008 . Available at

Full access

Peter R. Carroll and Andrew J. Vickers

Screening for prostate cancer has been a public health disaster,” announced Andrew J. Vickers, PhD, Attending Research Methodologist, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York City. At the

Full access

Heather Hampel

-Risk Assessment: Breast and Ovarian. Before 2014, detection and management of hereditary CRC was discussed within the NCCN Guidelines for Colorectal Cancer Screening. The repositioning of these recommendations is a reflection of the growing awareness of

Full access

Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole, Robert R. Bahnson, Erik P. Castle, William J. Catalona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth B. Etzioni, Thomas Farrington, George P. Hemstreet III, Mark H. Kawachi, Simon Kim, Paul H. Lange, Kevin R. Loughlin, William Lowrance, Paul Maroni, James Mohler, Todd M. Morgan, Kelvin A. Moses, Robert B. Nadler, Michael Poch, Chuck Scales, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Preston Sprenkle, Andrew J. Vickers, Robert Wake, Dorothy A. Shead and Deborah A. Freedman-Cass

, while minimizing unnecessary procedures and the detection of indolent disease. Population-based prostate cancer screening studies have shown survival benefits using prostate-specific antigen (PSA) levels, sometimes in combination with a digital rectal

Full access

Mariam Naveed, Meredith Clary, Chul Ahn, Nisa Kubiliun, Deepak Agrawal, Byron Cryer, Caitlin Murphy and Amit G. Singal

Background Over the past decade, colonoscopy use has increased dramatically in the United States. This is partly related to increasing uptake of colorectal cancer (CRC) screening examinations, but colonoscopy is often performed for other

Full access

Crystal S. Denlinger, Robert W. Carlson, Madhuri Are, K. Scott Baker, Elizabeth Davis, Stephen B. Edge, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Elizabeth Kvale, Terry S. Langbaum, Jennifer A. Ligibel, Mary S. McCabe, Kevin T. McVary, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Tracey O’Connor, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole McMillian and Deborah Freedman-Cass

the express written permission of NCCN®. These guidelines provide screening, evaluation, and treatment recommendations for common consequences of cancer and cancer treatment for health care professionals who work with survivors of adult

Full access

L. Stewart Massad

test used to improve diagnostic specificity after abnormal screening cytology. However, colposcopy is relatively invasive and costly and can be painful, and recent research has shown that the sensitivity of colposcopy is limited. 10 , 11 Other tests

Full access

J. Thomas Cox

MH . Advances in cervical screening technology . Mod Pathol 2000 ; 13 : 275 – 284 . 18 Hutchinson ML Isenstein LM Goodman A . Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep Processor . Am J Clin

Full access

Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole, Robert R. Bahnson, Daniel A. Barocas, Erik P. Castle, William J. Catalona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth B. Etzioni, Thomas Farrington, George P. Hemstreet III, Mark H. Kawachi, Paul H. Lange, Kevin R. Loughlin, William Lowrance, Paul Maroni, James Mohler, Todd M. Morgan, Robert B. Nadler, Michael Poch, Chuck Scales, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Preston Sprenke, Andrew J. Vickers, Robert Wake, Dorothy A. Shead and Deborah Freedman-Cass

Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the

Full access

Jeremy Matloff, Aimee Lucas, Alexandros D. Polydorides and Steven H. Itzkowitz

least 2 first- or second-degree relatives with Lynch-associated tumor, regardless of age. 4 The strategies for identifying those with LS continue to evolve as appropriate cancer screening and surveillance programs are initiated for at-risk individuals